Presentation TVT 2023 Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial Presenter: Brian Whisenant June 08, 2023
Presentation TVT 2023 Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS Presenter: Rahul Sharma June 08, 2023
Presentation TVT 2023 Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter? Presenter: Katherine Harrington June 08, 2023
Presentation TVT 2023 Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional) Presenter: Amar Krishnaswamy June 08, 2023
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News TVT 2021 Timing of Mitral Surgery After Failed TEER Influences Outcomes Todd Neale July 21, 2021
News Conference News TVT 2020 MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT Michael O'Riordan June 21, 2020
News Conference News TVT 2019 Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR Michael O'Riordan June 19, 2019
News Conference News TVT 2019 What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches? Michael O'Riordan June 14, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
News Conference News TVT 2019 PCI During or After TAVR No Riskier Than PCI Before Valve Replacement Michael O'Riordan June 13, 2019
News Conference News TVT 2016 To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights Shelley Wood June 17, 2016